CD274 and metastatic neoplasm: Meta‐analysis of studies enrolling patients with metastatic tumors revealed significant associations of PD‐L1+ CTCs with worse PFS (HR = 1.70, 95% CI 1.09–2.64) and OS (HR = 1.65, 95% CI 1.22–2.22) as shown in Figure 5.